Rezolute still has another Phase III trial of ersodetug in progress to rely upon, with data expected in H2 2026.

SyCipLaw: Recent amendments to the Foreign Investments Act (FIA) and Public Service Act (PSA) have liberalized foreign ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Sedna Africa is one such company actively shaping this narrative, proving that technological excellence is a valuable export ...

Lloyds has appointed Sandra Prince as Head of Consumer in its Corporate and Institutional Banking division, effective immediately, strengthening its leadership team at a time of rapid change in the ...